How Drug Delivery Systems Are Evolving for Faster Medication Administration

Getting medications into the body has become extremely important, especially when treatment can influence outcomes.

Traditional routes, including oral and injectable administration, remain important but have practical limitations. Oral medicines may be affected by gastrointestinal absorption and first-pass metabolism, while injections can require trained personnel, needles, and more time to administer.

Drug delivery is evolving as pharmaceutical developers increasingly look for ways to improve speed, consistency, bioavailability, and convenience.

Newer drug delivery solutions include particularly non-invasive routes such as intranasal administration.

Modern drug delivery is not solely about getting a medicine into the body. Increasingly, the goal is to deliver the right dose, through the right route, at the right time — particularly when every minute matters.

The Shift From Conventional to Advanced Drug Delivery

Drug delivery has evolved beyond simply choosing between tablets, capsules, and injections.

For decades, medications have primarily been administered through routes such as oral, intravenous, intramuscular, and subcutaneous delivery. Oral administration is common, but drugs taken by mouth must pass through the gastrointestinal tract, and factors such as digestion, absorption, and first-pass metabolism can affect how much active ingredient ultimately reaches the bloodstream. 

Intravenous administration, by contrast, delivers medication directly into the circulation and can provide rapid, predictable systemic exposure. But it requires a suitable vein, sterile equipment, and trained personnel. Intramuscular and subcutaneous injections can also provide systemic delivery while offering different absorption profiles depending on the drug and formulation.

This makes absorption rate and bioavailability important considerations when developing a medication. 

There is also increasing attention on reducing barriers to administration. Needles, clinical settings, complex dosing procedures, and the need for healthcare professionals can make some medications harder to administer, particularly when treatment must be given quickly.

As a result, patient-centred drug delivery systems are becoming an increasingly important area of pharmaceutical development. The focus is on how easily a drug can be administered, stored, transported, and used by patients or caregivers. Convenience, portability, dosing accuracy, tolerability, and the ability to administer treatment promptly can all influence the practical value of a delivery system.

Modern systems are being designed to address specific therapeutic needs rather than using a single administration method for every medication.

 Ongoing research is examining technologies ranging from nanocarriers and mucoadhesive formulations to specialized administration devices.

Why Speed Is Becoming a Major Consideration

There are situations where rapid medication administration can be particularly important, including:

• Acute allergic reactions
• Severe pain
• Seizures
• Migraine
• Nausea and vomiting
• Certain neurological conditions
• Emergency medical situations

The fastest route is not automatically the most appropriate one. Drug formulation, absorption characteristics, dose, patient condition, and the intended site of action all influence performance.

Intranasal Drug Delivery: A Growing Area of Innovation

Intranasal drug delivery is a non-invasive approach that can support local, systemic, and, in some applications, central nervous system delivery.

Key points:

• The nasal cavity has a highly vascularized mucosa.
• Intranasal administration can avoid gastrointestinal degradation and hepatic first-pass metabolism for certain drugs.
• Administration can be relatively simple and non-invasive.
• Researchers are investigating certain intranasal approaches for nose-to-brain delivery.
• Rapid absorption makes the route particularly interesting for medications where speed matters.

Current research continues to investigate intranasal formulations, delivery devices, nanoparticles, permeation enhancers, and mucoadhesive technologies. 

How Nasal Drug Delivery Is Being Improved

Nasal drug delivery has innovations such as:

• Dry-powder formulations
• Mucoadhesive formulations
• Nanoparticles and lipid-based carriers
• In-situ gels
• Permeation-enhancing technologies
• More precise nasal delivery devices
• Improved dose uniformity

Conventional liquid formulations can face issues including runoff, limited residence time, and variable absorption. Research has therefore explored different formulations and carriers to improve nasal retention and absorption.

5. Powder-Based Drug Delivery and the Push for Faster Absorption

Powder formulations are one of the approaches being developed to improve nasal drug administration.

Nasax® platform uses a powder formulation containing uniform-sized spherical API and an inhalation-approved carrier. The company says the platform is designed to promote rapid and precise delivery to the bloodstream and brain, while stability data indicate potential advantages in shelf life compared with liquid formulations.

Powder formulations are attracting attention because they have:

• Greater surface-area coverage within the nasal cavity
• Reduced liquid runoff
• Potentially more consistent deposition
• Portability
• Potential stability advantages

What Makes a Novel Drug Delivery System Effective?

A successful novel drug delivery system must balance multiple factors:

1. Speed of absorption
2. Bioavailability
3. Dose consistency
4. Formulation stability
5. Patient usability
6. Safety and tolerability
7. Manufacturing scalability
8. Regulatory requirements

Remaining Challenges in Drug Delivery Innovation

• Limited nasal dose volume
• Mucociliary clearance
• Nasal irritation
• Variability caused by congestion or other nasal conditions
• Difficulty delivering certain large molecules
• Formulation stability
• Device performance
• Regulatory and clinical requirements

Research reviews identify several of these issues as continuing barriers to wider adoption of nasal delivery technologies.

Where Drug Delivery Systems Are Heading

The future of drug delivery solutions is likely to focus on:

• Faster onset
• More predictable pharmacokinetics
• Greater patient convenience
• Non-invasive administration
• Better formulation stability
• Targeted delivery
• Portable emergency medications
• Personalized treatment approaches

Emergency medicine is where speed and ease of administration can be particularly valuable.

Nasus Pharma’s current pipeline illustrates this focus, with the company developing powder-based intranasal therapies for acute indications, including its NS002 epinephrine program for anaphylaxis.

Conclusion

The evolution of drug delivery is about more than replacing one route of administration with another. It is about making medicines faster, easier to administer, more stable, and better suited to specific clinical circumstances.

As formulation science, delivery devices, and pharmaceutical technologies continue to converge, faster and more practical administration methods could become an increasingly important part of the next generation of drug delivery.